Tag: FDA bioequivalence

Narrow therapeutic index drugs require stricter bioequivalence standards to prevent dangerous side effects or treatment failure. Learn how the FDA, EMA, and Health Canada regulate generics of critical medications like warfarin and levothyroxine.